Novel renal medullary carcinoma cell lines, UOK353 and UOK360 , provide preclinical tools to identify new therapeutic treatments-Reference-Cited by-同舟云学术

Novel renal medullary carcinoma cell lines, UOK353 and UOK360 , provide preclinical tools to identify new therapeutic treatments

Published:2020-04-17 Issue:8 Volume:59 Page:472-483
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosomes Cancer

Author:

Wei Darmood¹,Yang Youfeng¹,Ricketts Christopher J.¹,Vocke Cathy D.¹,Ball Mark W.¹,Sourbier Carole¹,Wangsa Darawalee²,Wangsa Danny²,Guha Rajarshi³,Zhang Xiaohu³,Wilson Kelli³,Chen Lu³,Meltzer Paul S.²,Ried Thomas²^ORCID,Thomas Craig J.³,Merino Maria J.⁴,Linehan W. Marston¹^ORCID

Affiliation:

1. Urologic Oncology Branch, Center for Cancer Research National Cancer Institute, National Institutes of Health Bethesda Maryland United States

2. Genetics Branch, Center for Cancer Research National Cancer Institute, National Institutes of Health Bethesda Maryland United States

3. Division of Preclinical Innovation, National Center for Advancing Translational Sciences National Institutes of Health Rockville Maryland United States

4. Laboratory of Pathology National Cancer Institute, National Institutes of Health Bethesda Maryland United States

Funder

Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research

NCATS Division of Preclinical Innovation

Publisher

Wiley

Subject

Cancer Research,Genetics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/gcc.22847

Reference30 articles.

1. Renal Medullary Carcinoma The Seventh Sickle Cell Nephropathy